Physician profile
Kathleen Gerbert
NPI 1891782967
$1,052.75
in general payments reported to CMS, 2019-2025
14 companies · $31.03 in 2025
The $31.03 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $15.05 · 2021: $200 · 2022: $94.02 · 2023: $110 · 2024: $476 · 2025: $31.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.99 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $303.92 | 2023-2024 | Veozah |
| Pfizer INC. | $130.09 | 2019-2023 | |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Urovant Sciences INC | $118.79 | 2021 | |
| Minerva Surgical, INC | $94.71 | 2019 | |
| Abbvie INC. | $69.02 | 2021-2023 | |
| Sage Therapeutics, LLC | $41.27 | 2023-2024 | |
| Exeltis, USA INC. | $34.28 | 2024-2025 | Slynd, Twirla |
| Sumitomo Pharma America, INC. | $31.01 | 2024-2025 | Myfembree |
| Coopersurgical, INC. | $28.48 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $21.34 | 2022 | |
| Therapeuticsmd, INC. | $20.36 | 2022 | |
| Becton, Dickinson and Company | $19.43 | 2019 | |
| Hologic Sales and Service, LLC | $15.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Gerbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.